Alcoholic and non-alcoholic fatty liver disease: Focus on ceramide

Pharmacology, Toxicology and Pharmaceutical Science

• Nonalcoholic Fatty Liver 100%
• Ceramide 100%
• Disease 80%
• Fatty Liver 60%
• Sphingolipid 60%
• Lipid 40%
• Animal 20%
• Organisms 20%
• Malignant Neoplasm 20%
• Etiology 20%
• Metabolic Syndrome X 20%
• Inflammation 20%
• Enzymes 20%
• Sphingomyelin Phosphodiesterase 20%

Biochemistry, Genetics and Molecular Biology

• Ceramide 100%
• Sphingolipid 40%
• Animal Models 20%
• Lipid 20%
• Lipid Metabolism 20%
• Enzyme 20%
• Regulatory Mechanism 20%
• Comprehension 20%
• Species 20%
• Stress 20%
• Organisms 20%
• Lipidomics 20%
• Immunity 20%
• Lipid Liver Level 20%
• Sphingolipid Metabolism 20%
• Acid Sphingomyelinase 20%
• Sphingomyelin Phosphodiesterase 20%
• Genomics 20%